- 1、本文档共45页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
该不该处理 STEMI患者的非“罪犯”病变
MACE All-cause Mortality Repeat Revascularisation Repeat Myocardial Infarction Cardiovascular Mortality 指南更新 欧洲重建指南2014 欧洲重建指南2014:STEMI 实践 50-70% 70-90% 90% Immediate PCI Staged PCI Medical therapy Immediate PCI Immediate PCI Staged PCI Staged PCI Medical therapy Medical therapy Management of Non-Culprit Lesions Identified at the time of Primary PCI Preventive PCI No Preventive PCI Increase Procedure time (minutes) 63 45 40% Procedure time and radiation Radiation dose (Gycm2) 90 71 27% 理解指南 可以 ≠ 必须 It remains to be determined how clinicians can identify lesions that should be revascularized beyond the culprit lesion and whether complete revascularization should be performed in single- or multi-stage procedures. At present, multivessel PCI during STEMI should be considered in patients with cardiogenic shock in the presence of multiple, critical stenoses or highly unstable lesions (angiographic signs of possible thrombus or lesion disruption), and if there is persistent ischaemia after PCI on the supposed culprit lesion. ESC guideline 2014 小结 PCI完全重建显示获益 STEMI患者亦然 重建时机值得讨论 新的证据支持直接PCI时完全重建 应考虑患者耐受和治疗条件 谢谢! In patients with multivessel disease who underwent percutaneous coronary intervention (PCI) during the era of first-generation drug-eluting stents (DES), incomplete revascularization heightened the risk of mortality at 5 years, according to a study published online June 4, 2013, ahead of print in the?American Journal of Cardiology. Edward L. Hannan, PhD, of the University at Albany, State University of New York (Albany, NY), and colleagues conducted a database analysis using the Percutaneous Coronary Intervention Reporting System of New York State and the Cardiac Surgery Reporting System to identify 21,767 patients with multivessel disease who underwent stenting from October 2003 to December 2005. The investigators also used the National Center for Health Statistics National Death Index to track all-cause mortality over a median of 3.9 years. Complete revasc
文档评论(0)